Geiger Counter Ltd Geiger Counter - GCS - Director/PDMR Shareholding

Geiger Counter

12/05/2026 15:35

RNS Number : 0350E

Geiger Counter Ltd

12 May 2026

 

THIS ANNOUNCEMENT CONTAINS INFORMATION THAT IS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) No. 5985/2014 WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED

 

Geiger Counter Limited (or the "Company")

12 May 2026

Director Subscriptions

 

Further to the announcement by the Company on 30 March 2026, in respect of the right to subscribe for Ordinary Shares in the Company, the following directors have subscribed for the following Subscription Shares:

Director
Position
Amount (£) subscribed for
Number of Subscription Shares subscribed for
Total Ordinary Shares held on Admission
Gary Clark
Chairman
18,607
50,020
300,122
James Leahy
Non Executive Director
8,496
22,838
137,032
Total
27,103
72,858
437,154

 

Related party transactions

The Director subscriptions set out in the table above are each related party transactions. The Directors consider that the terms of the Director's subscriptions are fair and reasonable insofar as shareholders are concerned.

 

Enquiries

 

Manulife | CQS Investment Management
Craig Cleland
T: +44 (0) 20 7201 5368
Cavendish Capital Markets Limited
Tunga Chigovanyika
(Corporate Finance)
T: +44 (0) 20 7397 1915
Daniel Balabanoff / Pauline Tribe (Sales)
T: +44 (0) 20 7220 0500
Summit Fund Services Jersey Limited
Christopher Foulds
T:+44 (0) 1534 825 259

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHFLFVSESIFLIR